Arbutus Biopharma (ABUS) News Today

→ A.I. “Perfect Storm” Could Send THESE Stocks Sky High (From InvestorPlace) (Ad)

$2.97

+0.06 (+2.06%)

(As of 04/15/2024 ET)

Source

Source	Headline
	Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Up 10.2% in March americanbankingnews.com - April 16 at 4:44 AM
	Arbutus Biopharma: The Markman Win Is A Good Milestone But Uncertainty Remains seekingalpha.com - April 10 at 7:31 AM
	Arbutus Biopharma (NASDAQ:ABUS) Trading 8% Higher americanbankingnews.com - April 7 at 2:16 AM
	Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge msn.com - April 4 at 4:37 PM
	Arbutus Biopharma (NASDAQ:ABUS) Sees Unusually-High Trading Volume marketbeat.com - April 4 at 2:02 PM
	Arbutus Biopharma Reports Claim Construction Ruling In Patent Infringement Lawsuit Against Moderna markets.businessinsider.com - April 4 at 10:42 AM
	Arbutus Biopharma (NASDAQ:ABUS) Earns "Market Outperform" Rating from JMP Securities marketbeat.com - April 4 at 9:15 AM
	Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna globenewswire.com - April 4 at 8:30 AM
	Arbutus Biopharma (NASDAQ:ABUS) Hits New 52-Week High at $3.25 marketbeat.com - April 3 at 4:30 PM
	Arbutus Biopharma jumps after claim construction order in patent fight with Moderna seekingalpha.com - April 3 at 1:17 PM
	marketbeat.com - April 3 at 12:22 PM
	Is Arbutus Biopharma (NASDAQ:ABUS) In A Good Position To Deliver On Growth Plans? finance.yahoo.com - April 1 at 3:37 PM
	ABUS Jan 2025 7.000 call finance.yahoo.com - March 19 at 10:43 AM
	Hudson Bay Capital Management LP Purchases 1,302,978 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) marketbeat.com - March 14 at 7:25 AM
	Arbutus Biopharma to Participate in Prominent Investor Conferences msn.com - March 12 at 12:37 AM
	Arbutus to Participate in Two Upcoming Investor Conferences globenewswire.com - March 8 at 7:30 AM
	Arbutus Biopharma Target of Unusually Large Options Trading (NASDAQ:ABUS) marketbeat.com - March 6 at 1:53 PM
	FY2024 EPS Estimates for Arbutus Biopharma Co. Raised by Chardan Capital (NASDAQ:ABUS) marketbeat.com - March 6 at 8:13 AM
	Arbutus Biopharma Corporation (NASDAQ:ABUS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report finance.yahoo.com - March 3 at 12:08 PM
	Analysts Just Made A Major Revision To Their Arbutus Biopharma Corporation (NASDAQ:ABUS) Revenue Forecasts finance.yahoo.com - March 2 at 10:36 AM
	Arbutus Biopharma (NASDAQ:ABUS) Releases Quarterly Earnings Results, Meets Estimates marketbeat.com - March 1 at 4:13 PM
	Arbutus Biopharma (NASDAQ:ABUS) Given New $5.00 Price Target at HC Wainwright marketbeat.com - March 1 at 8:33 AM
	Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2023 Earnings Call Transcript finance.yahoo.com - March 1 at 8:33 AM
	Arbutus Biopharma (NASDAQ:ABUS) Receives "Buy" Rating from Chardan Capital marketbeat.com - March 1 at 8:28 AM
	Buy Rating Affirmed for Arbutus Biopharma on Strong Clinical Outlook and Litigation Prospects markets.businessinsider.com - March 1 at 1:26 AM
	Q4 2023 Arbutus Biopharma Corp Earnings Call finance.yahoo.com - March 1 at 1:26 AM
	Arbutus Biopharma Corporation: Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update finanznachrichten.de - February 29 at 10:24 AM
	Arbutus Biopharma Corp (ABUS) Reports Year-End Financial Results and Progress in Clinical Trials finance.yahoo.com - February 29 at 10:24 AM
	Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update globenewswire.com - February 29 at 7:30 AM
	ABUS Jun 2024 3.000 put finance.yahoo.com - February 28 at 12:54 AM
	ABUS Apr 2024 6.000 call finance.yahoo.com - February 27 at 8:05 AM
	ABUS Apr 2024 3.000 call finance.yahoo.com - February 23 at 2:49 AM
	ABUS Sep 2024 3.000 call finance.yahoo.com - February 23 at 2:49 AM
	Arbutus Biopharma Set to Announce 2023 Year-End Financial Results, Offering Insight into Hepatitis B Cure Progress msn.com - February 17 at 7:29 AM
	Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update finance.yahoo.com - February 15 at 9:04 AM
	Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update globenewswire.com - February 15 at 7:30 AM
	Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200 Day Moving Average of $2.10 marketbeat.com - February 15 at 3:11 AM
	Arbutus Biopharma gains after Markman hearing on Thursday in Moderna dispute msn.com - February 9 at 4:20 PM
	Arbutus Biopharma (NASDAQ:ABUS) Stock Price Crosses Above Two Hundred Day Moving Average of $2.08 marketbeat.com - February 7 at 7:23 AM
	The past three years for Arbutus Biopharma (NASDAQ:ABUS) investors has not been profitable finance.yahoo.com - February 2 at 1:00 PM
	Arbutus Biopharma Corporation (ABUS) ca.finance.yahoo.com - January 31 at 11:27 PM
	Arbutus Biopharma Corporation (ABUS) ca.finance.yahoo.com - January 31 at 11:27 PM
	Chardan Capital Reaffirms Their Buy Rating on Arbutus Biopharma (ABUS) markets.businessinsider.com - January 30 at 7:18 AM
	Arbutus Biopharma (NASDAQ:ABUS) Shares Pass Above 200 Day Moving Average of $2.07 marketbeat.com - January 30 at 3:03 AM
	Optimistic Outlook for Arbutus Biopharma Amid Anticipated Positive Data and Strategic Pipeline Developments markets.businessinsider.com - January 11 at 1:13 PM
	Arbutus Biopharma: A Buy Rating on Strong Financial Footing and Promising Clinical Prospects markets.businessinsider.com - January 10 at 9:33 AM
	Arbutus Biopharma reports 2023 cash position of ~$132M as of Dec. 31, 2023 msn.com - January 8 at 2:31 PM
	Arbutus Biopharma Corporation: Arbutus Announces 2024 Corporate Objectives and Provides Financial Update finanznachrichten.de - January 8 at 9:30 AM
	Arbutus Announces 2024 Corporate Objectives and Provides Financial Update finance.yahoo.com - January 8 at 9:30 AM
	Institutions own 30% of Arbutus Biopharma Corporation (NASDAQ:ABUS) shares but individual investors control 32% of the company finance.yahoo.com - January 1 at 8:38 AM

Get Arbutus Biopharma News Delivered to You Automatically

Elon Musk’s ChatGPT Could Soon Mint New Millionaires (Ad)

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

ABUS Media Mentions By Week

ABUS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABUS
News Sentiment
▼
1.03

0.66
▲
Average
Medical
News Sentiment

ABUS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABUS Articles
This Week
▼
4

2
▲
ABUS Articles
Average Week

Get Arbutus Biopharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:ABUS) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Arbutus Biopharma (ABUS) News Today

ABUS Media Mentions By Week

ABUS Media Sentiment

ABUS News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info